Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bluebird-Bio
Company Monitoring Page for Bluebird-Bio
latest headlines for company on cafepharma
Myeloma cell therapies, now in pharma hands, move into spotlight
Biopharma Dive
Sat, 12/7/19 - 11:47 pm
Tags:
ASH2019
,
cell therapies
,
Multiple Myeloma
,
Bluebird Bio
,
Bristol-Myers Squibb
,
ide-cel
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
Tags:
ASH2019
,
Roche
,
Bristol-Myers Squibb
,
Acadia Pharmaceuticals
,
Biogen
,
Cassava Sciences
,
Alector
,
GW Pharma
,
Magenta Therapeutics
,
Fortress Biotech
,
Mustang Bio
,
Bluebird Bio
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Reuters
Wed, 11/27/19 - 12:36 pm
Tags:
gene therapy
,
drug manufacturing
,
Pfizer
,
Novartis
,
Bluebird Bio
,
PTC Therapeutics
,
Krystal Biotech
Bluebird gets European green light for gene therapy production
Biopharma Dive
Fri, 10/25/19 - 10:34 am
Tags:
Bluebird Bio
,
gene therapy
,
Europe
,
Zynteglo
Why Novo Nordisk should buy Uniqure
EP Vantage
Fri, 10/11/19 - 10:31 am
Tags:
Novo Nordisk
,
gene editing
,
hemophilia
,
uniQure
,
Bluebird Bio
Novo taps bluebird bio for gene-editing tech
Fierce Biotech
Wed, 10/9/19 - 09:43 am
Tags:
Novo Nordisk
,
Bluebird Bio
,
R&D
,
gene editing
,
hemophilia
bluebird presents long-term data from CALD gene therapy
Pharmaforum
Fri, 09/20/19 - 09:28 am
Tags:
Bluebird Bio
,
gene therapy
,
cALD
,
Lenti-D
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Sun, 09/15/19 - 10:05 pm
Tags:
Merck
,
Pifeltro
,
FDA
,
Delstrigo
,
Novo Nordisk
,
oral semaglutide
,
Kodiak Sciences
,
MeiraGTx Holdings
,
IPOs
,
Exagen
,
IGM Biosciences
,
Arrowhead Pharmaceuticals
,
Lexicon Pharmaceuticals
,
Bluebird Bio
,
vTv Therapeutics
bluebird bio Prepares for Launch
Motley Fool
Thu, 08/8/19 - 10:22 am
Tags:
Bluebird Bio
,
Zynteglo
,
beta-thalassemia
,
drug launches
Bluebird Bio (BLUE) Reports Q2 Loss, Tops Revenue Estimates
Yahoo/Zacks.com
Fri, 08/2/19 - 11:46 pm
Tags:
Bluebird Bio
,
earnings
Where Will bluebird bio Be in 1 Year?
Motley Fool
Fri, 06/21/19 - 09:58 am
Tags:
Bluebird Bio
,
bb2121
,
Zynteglo
What Bluebird Bio Gets Wrong In Pricing For Its $1.8 Million Drug
Forbes
Wed, 06/19/19 - 09:55 am
Tags:
Bluebird Bio
,
gene therapy
,
drug pricing
,
Zynteglo
,
beta thalassemia
Bluebird delays gene therapy launch to 2020, citing manufacturing tweaks
Biopharma Dive
Tue, 06/18/19 - 11:57 am
Tags:
Bluebird Bio
,
gene therapy
,
drug manufacturing
,
Zynteglo
bluebird offers installment payments for Zynteglo gene therapy
Pharmaforum
Mon, 06/17/19 - 12:25 pm
Tags:
Bluebird Bio
,
outcome-based pricing
,
drug pricing
,
gene therapy
,
Zynteglo
,
beta thalassemia
Is $1.8 Million for bluebird bio's New Gene Therapy Ridiculous?
Motley Fool
Sat, 06/15/19 - 05:49 pm
Tags:
Bluebird Bio
,
Zynteglo
,
drug pricing
,
beta thalassemia
Bluebird sets $1.8M price tag for blood-disease gene therapy
Biopharma Dive
Fri, 06/14/19 - 12:08 pm
Tags:
drug pricing
,
Bluebird Bio
,
Zynteglo
,
Europe
,
beta thalassemia
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
Tags:
ADA
,
Merck
,
Keytruda
,
NGM Biopharmaceuticals
,
NGM313/MK-3655
,
Corbus Pharmaceuticals
,
Nektar
,
Galapagos
,
Kezar Life Sciences
,
Kura Oncology
,
Bluebird Bio
,
BeiGene
,
Global Blood Therapeutics
,
Blueprint Medicines
,
Regeneron
,
Arqule
,
Sunesis
,
Sutro BioPharma
,
Incyte
,
Geron
,
Forty Seven
Patients, payers await pricing plans for bluebird's first approved gene therapy
BioCentury
Tue, 06/4/19 - 11:04 am
Tags:
Bluebird Bio
,
gene therapy
,
Zynteglo
,
drug pricing
,
beta thalassemia
Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval
Xconomy
Mon, 06/3/19 - 07:50 pm
Tags:
Bluebird Bio
,
gene therapy
,
Europe
,
Zynteglo
,
EMA
,
beta thalassemia
Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big
Motley Fool
Sun, 05/19/19 - 04:05 pm
Tags:
Alexion
,
Ultomiris
,
AbbVie
,
Upadacitinib
,
risankizumab
,
Aimmune Therapeutics
,
AR-101
,
Bluebird Bio
,
LentiGlobin
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.